MedPath

Different Manufacturing Techniques of Facial Prostheses

Not Applicable
Recruiting
Conditions
Facial Defects
Registration Number
NCT06864091
Lead Sponsor
Cairo University
Brief Summary

All participants will undergo 3-dimentional facial scan and the defect site will be scanned using intraoral scanner. the data will be extracted in Standard tessellation Language (STL) and used in virtual prosthesis reconstruction.

* (Group 1) involves direct printing of the final prosthesis using biocompatible rubber-like printable soft resin.

* Group 2, involves direct manufacturing of the negative mold, it will be virtually designed based on an inverted STL file of prosthesis prototype/ pattern.

* Group 3, involves fabrication of the negative mold indirectly by printing the prosthesis prototype from resin and then duplicating it into wax and a conventional stone mold will be fabricated.

* The negative molds of both groups 2\&3 will be used in packing medical grade silicone (to cast the final prosthesis.

* All final prostheses will be colored and characterized to match the surrounding anatomy.

* Esthetic outcomes will be assessed using VAS scale by answering operator and patient related questionnaires. The patient related questionnaire will be translated to the patients and responses will be recorded. For each patient, a score will be given from 1-5.

* Prosthesis accuracy will be assessed using Medit software, comparing the scan of the final prosthesis to the STL of the prosthesis design and the root mean square (RMS) will be recorded.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5
Inclusion Criteria
  1. Patients with cartilaginous facial defects, i.e: auricular and nasal defects.
  2. Patients between 20-60 years old.
  3. Post traumatic patients with facial defects.
  4. Patients with congenital facial defects.
  5. Patients with failed facial surgical construction.
  6. Compliant and cooperative patients.
Exclusion Criteria

1 - Patients having risk of tumor recurrence in the defect area. 2- Patients undergoing radiotherapy or chemotherapy treatment. 3- Patients with any debilitating disease. 4- Patients with any type of psychosomatic disorder. 5- Patients with allergy to any of the materials used.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Esthetic Outcomes3 months

Esthetic outcomes will be assessed using VAS scale by answering operator and patient related questionnaires. The patient related questionnaire will be translated to the patients and responses will be recorded. For each patient, a score will be given from 1-5.

Secondary Outcome Measures
NameTimeMethod
Prosthesis Accuracy3 months

Prosthesis accuracy will be assessed using Medit software, comparing the scan of the final prosthesis to the STL of the prosthesis design and the root mean square (RMS) will be recorded.

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath